NEURO Imaging
|
|
750 – 800 |
Welcome Remarks |
800-825 |
Reporting brain mets and follow up |
825-850 |
Reporting spinal mets and follow up |
850-915 |
Reporting metrics for CTA: stroke, BCVI and brain death evaluation |
915-940 |
Primer in reporting CT perfusion |
940-1000 |
Discussion & Q&A |
1000 |
Break |
Moderator(s): Shobit Mathur |
|
1015-1040 |
Primer in reporting neurodegenerative diseases |
1040-1105 |
New MS guidelines, and MS reporting |
1105-1130 |
Sella Reporting Guidelines |
11301155 |
Scoring of Hypoxic-Ischemic Encephalopathy |
1155-1215 |
Discussion & Q&A |
1215-1300 |
Lunch |
MSK Imaging
|
|
1300-1325 |
Categorization of Peripheral Nerve Injury: Clinical and Imaging Classification |
1325-1350 |
Best practice guidelines in imaging assessment of femoroacetabular impingement |
1350-1415 |
Nomenclature for Musculoskeletal Infection on MRI |
1415-1440 |
Nomenclature of Subchondral Non-neoplastic Bone Lesions |
1440-1500 |
Discussion & Q&A |
1500-1515 |
Break |
Moderator(s): Lawrence White |
|
1515-1540 |
Contrast use in MSK MRI: When is non-contrast imaging enough? |
1540-1605 |
Guidelines for utilization and performance of direct MR arthrography |
1605-1630 |
Classification systems in MSK Spine Trauma |
1630-1655 |
Guidelines on BMD Reporting |
1655-1715 |
Discussion & Q&A |